Return to the Faculty List

Kevin J. Black, MD

Current Position
Professor of Psychiatry

Education and Training
B.S., mathematics: Brigham Young University, Provo, Utah, 1986
Medical Degree: Duke University School of Medicine, Durham, North Carolina, 1990
Residency: Psychiatry, Barnes-Jewish Hospital, Washington University, St. Louis, Missouri, 1994
Fellowship: Movement Disorders and Neuroimaging, Washington University, St. Louis, Missouri, 1996

Major Awards
Certification in Behavioral Neurology and Neuropsychiatry, United Council for Neurologic Subspecialties (UCNS), 2006, 2016
Listed in Castle Connolly's American's Top Doctors, 2009-2016
Elected by his peers for inclusion in Best Doctors in America®, 2005-2016
Named a Fellow of the American Neuropsychiatric Association, 2006
Hope Award from the St. Louis chapter of the HDSA (Huntington Disease Society of America), 2006
American College of Neuropsychopharmacology (ACNP) / Bristol-Myers Squibb Travel Award, 2001
NARSAD Young Investigator Awards, 1996 and 1999
Upjohn Resident Research Award, Washington University Department of Psychiatry, 1994
Southern Psychiatric Association Annual Award for Psychiatrists in Training, 1993
Mead Johnson Fellow in Academic Psychiatry, Association for Academic Psychiatry, 1993

Areas of Clinical Interest
Tourette syndrome (TS) and other tic disorders, neuropsychiatry of Parkinson's disease and dystonia, Huntington's disease, tardive dyskinesia, catatonia, psychogenic or atypical movement disorders


Areas of Research Interests
Neuroimaging methods development including pharmacological fMRI.
Tourette syndrome (TS) and other tic disorders.
Neuroimaging and clinical studies in TS and other movement disorders.
Methods development for analyzing results of deep brain stimulation (DBS).

More articles and abstracts at the National Library of Medicine

Key Publications
*Greene DJ, *Williams AC III, Koller JM, Schlaggar BL, Black KJ, The Tourette Association of America Neuroimaging Consortium (2016). Brain structure in pediatric Tourette syndrome. Mol Psychiatry. 22(7): 972-80. PubMed PMID: 27777415 PubMedCentral PMCID: PMC5405013 DOI: 10.1038/mp.2016.194
*Equal contributors  Full Article ->

Black KJ, Black ER, Greene DJ, Schlaggar BL (2016). Provisional Tic Disorder: what to tell parents when their child first starts ticcing [version 1]. F1000Res 5:696. PubMed PMID: 27158458 PubMedCentral PMCID: PMC4850871 DOI: 10.12688/f1000research.8428.1  Full Article ->

Koller JM, Vachon MJ, Bretthorst GL, Black KJ (2016 April). Rapid quantitative pharmacodynamic imaging with Bayesian estimation. Front Neurosci. 10: 144. PubMed PMID: 27092045 PubMedCentral PMCID: PMC4825616 DOI: 10.3389/fnins.2016.00144  Full Article ->

Greene DJ, Church JA, Dosenbach NUF, Nielsen AN, Adeyemo B, Nardos B, Petersen SE, Black KJ, Schlaggar BL (2016). Multivariate pattern classification of pediatric Tourette syndrome using functional connectivity MRI. Dev Sci. 19(4): 581-98. PubMed PMID: 26834084 PubMedCentral PMCID: PMC4945470 DOI: 10.1111/desc.12407  Full Article ->

Eisenstein SA, Koller JM, Black KD, Campbell MC, Lugar HM, Ushe M, Tabbal SD, Karimi M, Hershey T, Perlmutter JS, Black KJ (2014 Aug). Functional anatomy of subthalamic nucleus stimulation in Parkinson disease. Ann Neurol. 76(2): 279-95. PubMed PMID 24953991 PubMedCentral PMCID: PMC4172323 DOI: 10.1002/ana.24204  Full Article ->

Black KJ, Koller JM, Campbell MC, Gusnard DA, Bandak SI (2010 Dec 1). Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease. J Neurosci. 30(48): 16284-92. PubMed PMID 21123574 PubMedCentral PMCID: PMC3008651 DOI: 10.1523/JNEUROSCI.2590-10.2010  Full Article ->

Funded Research Projects
NIMH (PI):The New Tics study: A novel approach to pathophysiology and cause of tic disorders
Michael J. Fox Foundation for Parkinson's Research (PI):Dopamine buffering capacity measured by phMRI as a novel biomarker of disease progression in PD
NIDDK (Significant Contributor):Early Predictors of Brain Health and Development in Youth with T1DM
Tourette Association of America (Significant Contributor):Testing a Pathophysiological Model of Complex Tics
ACADIA Pharmaceuticals (site PI): An Open-label, 8-Week Study of Safety and Efficacy for Adjunctive Pimavanserin Treatment in Adults With Parkinson’s Disease and Inadequately Controlled Depression (ACP-103-048)